image
Healthcare - Biotechnology - NASDAQ - US
$ 1.36
-6.85 %
$ 6.09 M
Market Cap
-0.01
P/E
BALANCE SHEET
632 K ASSETS
-89.32%
3.23 M LIABILITIES
12.39%
-2.59 M EQUITY
-85.18%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Alzamend Neuro, Inc.
image
Current Assets 455 K
Cash & Short-Term Investments 376 K
Receivables 0
Other Current Assets 79.2 K
Non-Current Assets 176 K
Long-Term Investments 0
PP&E 176 K
Other Non-Current Assets 0
Current Liabilities 3.23 M
Accounts Payable 2.93 M
Short-Term Debt 301 K
Other Current Liabilities 0
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Apr-2024 Apr-2023 Apr-2022 Apr-2021 Apr-2020 Apr-2019 Apr-2018 Apr-2017 Apr-2016
ASSETS
Cash & Cash Equivalents 0.4 5.1 14.1 1.9 90.3 K 42.6 K 0.5 4.98 K 1.14 K
Short Term Investments 0 0 0 0 0 0 0 0 0
Receivables 0 0 0 16.2 K 0.2 0.3 0 0 0
Inventory 0 0 0 16.2 K 0 0 0 0 0
Other Current Assets 79.2 K 0.7 0.3 0.6 1.5 1.2 1.9 52.3 K 4.47 K
Total Current Assets 0.5 5.8 14.4 2.9 1.8 1.5 2.4 57.3 K 5.61 K
PP&E 0.2 79.8 K 0.1 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 0 0 0.4 0 0 0 75 K 25 K
Other Assets 0 0 0 (0.4) 0 0 0 0 0
Total Assets 0.6 5.9 14.5 2.9 1.8 1.5 2.4 0.1 30.6 K
LIABILITIES
Accounts Payable 2.9 2.9 1.2 0.5 0.9 1.1 90.1 K 0.1 2.6 K
Short Term Debt 0.3 0 0 0.3 62.7 79.3 0 0.6 3.12 K
Other Current Liabilities 0 0 2.08 K 60.7 K 62.6 K 79.3 K 6.64 K 0 25 K
Total Current Liabilities 3.2 2.9 1.2 0.9 1.0 1.2 96.7 K 0.7 30.7 K
Long Term Debt 0 0 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0 0
Total Liabilities 3.2 2.9 1.2 0.9 1.0 1.2 96.7 K 0.7 30.7 K
EQUITY
Common Stock 69 9.69 K 9.55 K 6.74 K 6.48 K 6.19 K 4.95 K 3.29 K 4.64 K
Retained Earnings (54.0) (44.1) (29.2) (16.8) (11.8) (7.4) (2.5) (1.6) 11.6 K
Other Accumulative Comprehensive Income/Loss 0 (14.9) (14.9) (14.9) (15.0) (15.0) 4.95 K 0 3 K
Total Equity (2.6) 3.0 13.4 2.0 0.8 0.3 2.3 (0.6) 106
Total Liabilities and Equity 0.6 5.9 14.5 2.9 1.8 1.5 2.4 0.1 30.6 K
SHARES OUTSTANDING
Common Shares Outstanding 0.7 0.7 0.6 0.5 0.5 0.4 0.6 0.2 0.2